Health System

AI Innovations Amid COVID-19

July 03, 2020

Drug Topics interviews Steve Mok, PharmD, BCPS, BCIDP, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence (AI) can mitigate challenges posed by the COVID-19 pandemic.

Over the Counter Episode 3: Remdesivir, A Top Contender for COVID-19 Treatment

July 02, 2020

In episode 3 of Over the Counter, experts weigh in on remdesivir, a potential COVID-19 treatment.

Coronavirus News Roundup: Gilead Sets Price for Remdesivir, New FDA and CDC Guidance Updates

July 02, 2020

Here's this week's roundup of the coronavirus-related news you should know.

APhA Connects with Pharmacy Technician Certification Board To Provide Immunization Training

June 30, 2020

A collaboration between APhA and PTCB will help provide pharmacy technician credentialing in immunization delivery.

New Machine Learning Tool Can Predict Adverse Drug Effects

June 29, 2020

A new computer algorithm might be the next step toward accurate prediction of adverse drug reactions.

Part 2: A Conversation on Remdesivir Trial Updates

June 29, 2020

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.

Gilead Sets Price of Remdesivir for COVID-19 Treatment

June 29, 2020

In an open letter, Gilead Chairman and CEO Daniel O’Day announced the price of remdesivir treatment for COVID-19.

Pharmacists: Fight Racial Disparities in Health Care

June 26, 2020

Today, pharmacists are banding together to “eliminate racism, discrimination, injustice, and the marginalization of individuals within the profession.”

Coronavirus News Roundup: Vaccine Trials Gaining Momentum, Pharmacists Fight Racism Amid COVID-19

June 26, 2020

Check out this week's most important coronavirus-related news.

Flu-Like Illness Surveillance Suggests Surge in Undetected US COVID-19 Cases

June 25, 2020

Existing surveillance networks can track influenza-like illness and lead to improved assessments on impact, prevalence, and severity of COVID-19.